Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users

Psychopharmacology (Berl). 2011 Mar;214(2):391-401. doi: 10.1007/s00213-010-2042-1. Epub 2010 Oct 30.

Abstract

Introduction: Previous research has shown that heavy cannabis users develop tolerance to the impairing effects of Δ9-tetrahydrocannabinol (THC) on neurocognitive functions. Animal studies suggest that chronic cannabis consumption may also produce cross-tolerance for the impairing effects of alcohol, but supportive data in humans is scarce.

Purpose: The present study was designed to assess tolerance and cross-tolerance to the neurocognitive effects of THC and alcohol in heavy cannabis users.

Methods: Twenty-one heavy cannabis users participated in a double-blind, placebo-controlled, three-way study. Subjects underwent three alcohol-dosing conditions that were designed to achieve a steady blood alcohol concentration of about 0, 0.5, and 0.7 mg/ml during a 5-h time window. In addition, subjects smoked a THC cigarette (400 μg/kg) at 3 h post-onset of alcohol dosing during every alcohol condition. Performance tests were conducted repeatedly between 0 and 7 h after onset of drinking and included measures of perceptual motor control (critical tracking task), dual task processing (divided-attention task), motor inhibition (stop-signal task), and cognition (Tower of London).

Results: Alcohol significantly impaired critical tracking, divided attention, and stop-signal performance. THC generally did not affect task performance. However, combined effects of THC and alcohol on divided attention were bigger than those by alcohol alone.

Conclusion: In conclusion, the present study generally confirms that heavy cannabis users develop tolerance to the impairing effects of THC on neurocognitive task performance. Yet, heavy cannabis users did not develop cross-tolerance to the impairing effects of alcohol, and the presence of the latter even selectively potentiated THC effects on measures of divided attention.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Administration, Oral
  • Adult
  • Alcohol Drinking / adverse effects
  • Alcohol Drinking / psychology*
  • Attention / drug effects
  • Central Nervous System Depressants / administration & dosage*
  • Central Nervous System Depressants / adverse effects
  • Central Nervous System Depressants / blood
  • Cognition / drug effects*
  • Double-Blind Method
  • Dronabinol / administration & dosage*
  • Dronabinol / adverse effects
  • Drug Tolerance*
  • Ethanol / administration & dosage*
  • Ethanol / adverse effects
  • Ethanol / blood
  • Executive Function / drug effects
  • Female
  • Humans
  • Impulsive Behavior
  • Male
  • Marijuana Abuse / complications
  • Marijuana Abuse / psychology*
  • Marijuana Smoking / adverse effects
  • Marijuana Smoking / psychology*
  • Motor Activity / drug effects
  • Neuropsychological Tests
  • Placebo Effect
  • Psychotropic Drugs / administration & dosage*
  • Psychotropic Drugs / adverse effects
  • Time Factors
  • Young Adult

Substances

  • Central Nervous System Depressants
  • Psychotropic Drugs
  • Ethanol
  • Dronabinol